Description
A non-nucleoside reverse transcriptase inhibitor; inhibits growth of wild-type (EC50 = 0.51 nM) and NNRTI-resistant HIV strains (EC50s = <1 nM for L100I, K103N, V106A, G190A, and G190S mutants); reduces the plasma viral titer in HIV-1 infected humanized mice when used in combination with cabotegravir, lamivudine, and abcavir
Formal name: 4-[[4-[[4-[(1E)-2-cyanoethenyl]-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]-benzonitrile
Synonyms: R278474|TMC278
Molecular weight: 366.4
CAS: 500287-72-9
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antivirals|Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)||Product Type|Biochemicals|Small Molecule Inhibitors|MMPs||Product Type|Biochemicals|Small Molecule Inhibitors|Reverse Transcriptases||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Viral Diseases|HIV & AIDS